Igen Biolab Group, AG

Patients suffering severe diseases, which often are life-threatening, are the focus of our efforts. This approach is the essential condition for the success of our work, in which not only our employees are involved, but also our partners and external collaborators. Our commitment to medical progress goes hand in hand with our commitment towards our patients: everyone who might benefit from our findings must have the opportunity to do so. This promise is extended to physicians and the community of all those involved in patient care. Functional protein immunotherapies help physicians and other healthcare professionals to provide high quality medical nutrition care and to improve patients’ quality of life. The staff at IGEN BIORESEARCH GROUP works every day in order to keep this promise. From our point of view, IGEN BIORESEARCH GROUPs portfolio developments represents a promise in itself. Not only does it represent an important potential for the company, but also new possibilities and new hopes for hundreds of thousands of people worldwide who are suffering oncologic and degenerative diseases. IGEN BIORESEARCH GROUP is working for them in terms of new approaches to Medicine, discovering a variety of biological activities from vegetal and animal sources, which entail a major potential in terms of therapy and preventive diagnosis.